Defining the characteristics and expectations of fluid bolus therapy: A worldwide perspective

Neil J. Glassford, Johan Mårtensson, Glenn M. Eastwood, Sarah L. Jones, Aiko Tanaka, Erica Wilkman, Michael Bailey, Rinaldo Bellomo, GLobal OBservational Evaluations in the ICU (GLOBE-ICU) investigators

Research output: Contribution to journalArticleResearchpeer-review

13 Citations (Scopus)

Abstract

Purpose The purpose of the study is to understand what clinicians believe defines fluid bolus therapy (FBT) and the expected response to such intervention. Methods We asked intensive care specialists in 30 countries to participate in an electronic questionnaire of their practice, definition, and expectations of FBT. Results We obtained 3138 responses. Despite much variation, more than 80% of respondents felt that more than 250 mL of either colloid or crystalloid fluid given over less than 30 minutes defined FBT, with crystalloids most acceptable. The most acceptable crystalloid and colloid for use as FBT were 0.9% saline and 4% albumin solution, respectively. Most respondents believed that one or more of the following physiological changes indicates a response to FBT: a mean arterial pressure increase greater than 10 mm Hg, a heart rate decrease greater than 10 beats per minute, an increase in urinary output by more than 10 mL/h, an increase in central venous oxygen saturation greater than 4%, or a lactate decrease greater than 1 mmol/L. Conclusions Despite wide variability between individuals and countries, clear majority views emerged to describe practice, define FBT, and identify a response to it. Further investigation is now required to describe actual FBT practice and to identify the magnitude and duration of the physiological response to FBT and its relationship to patient-centered outcomes.

Original languageEnglish
Pages (from-to)126-132
Number of pages7
JournalJournal of Critical Care
Volume35
DOIs
Publication statusPublished - 1 Oct 2016

Keywords

  • Critical care
  • Fluid bolus therapy
  • Fluid resuscitation
  • Hemodynamic optimization

Cite this

Glassford, N. J., Mårtensson, J., Eastwood, G. M., Jones, S. L., Tanaka, A., Wilkman, E., ... GLobal OBservational Evaluations in the ICU (GLOBE-ICU) investigators (2016). Defining the characteristics and expectations of fluid bolus therapy: A worldwide perspective. Journal of Critical Care, 35, 126-132. https://doi.org/10.1016/j.jcrc.2016.05.017
Glassford, Neil J. ; Mårtensson, Johan ; Eastwood, Glenn M. ; Jones, Sarah L. ; Tanaka, Aiko ; Wilkman, Erica ; Bailey, Michael ; Bellomo, Rinaldo ; GLobal OBservational Evaluations in the ICU (GLOBE-ICU) investigators. / Defining the characteristics and expectations of fluid bolus therapy : A worldwide perspective. In: Journal of Critical Care. 2016 ; Vol. 35. pp. 126-132.
@article{6d7c313387424c29906e552c522c66db,
title = "Defining the characteristics and expectations of fluid bolus therapy: A worldwide perspective",
abstract = "Purpose The purpose of the study is to understand what clinicians believe defines fluid bolus therapy (FBT) and the expected response to such intervention. Methods We asked intensive care specialists in 30 countries to participate in an electronic questionnaire of their practice, definition, and expectations of FBT. Results We obtained 3138 responses. Despite much variation, more than 80{\%} of respondents felt that more than 250 mL of either colloid or crystalloid fluid given over less than 30 minutes defined FBT, with crystalloids most acceptable. The most acceptable crystalloid and colloid for use as FBT were 0.9{\%} saline and 4{\%} albumin solution, respectively. Most respondents believed that one or more of the following physiological changes indicates a response to FBT: a mean arterial pressure increase greater than 10 mm Hg, a heart rate decrease greater than 10 beats per minute, an increase in urinary output by more than 10 mL/h, an increase in central venous oxygen saturation greater than 4{\%}, or a lactate decrease greater than 1 mmol/L. Conclusions Despite wide variability between individuals and countries, clear majority views emerged to describe practice, define FBT, and identify a response to it. Further investigation is now required to describe actual FBT practice and to identify the magnitude and duration of the physiological response to FBT and its relationship to patient-centered outcomes.",
keywords = "Critical care, Fluid bolus therapy, Fluid resuscitation, Hemodynamic optimization",
author = "Glassford, {Neil J.} and Johan M{\aa}rtensson and Eastwood, {Glenn M.} and Jones, {Sarah L.} and Aiko Tanaka and Erica Wilkman and Michael Bailey and Rinaldo Bellomo and {GLobal OBservational Evaluations in the ICU (GLOBE-ICU) investigators}",
year = "2016",
month = "10",
day = "1",
doi = "10.1016/j.jcrc.2016.05.017",
language = "English",
volume = "35",
pages = "126--132",
journal = "Journal of Critical Care",
issn = "0883-9441",
publisher = "Elsevier",

}

Glassford, NJ, Mårtensson, J, Eastwood, GM, Jones, SL, Tanaka, A, Wilkman, E, Bailey, M, Bellomo, R & GLobal OBservational Evaluations in the ICU (GLOBE-ICU) investigators 2016, 'Defining the characteristics and expectations of fluid bolus therapy: A worldwide perspective', Journal of Critical Care, vol. 35, pp. 126-132. https://doi.org/10.1016/j.jcrc.2016.05.017

Defining the characteristics and expectations of fluid bolus therapy : A worldwide perspective. / Glassford, Neil J.; Mårtensson, Johan; Eastwood, Glenn M.; Jones, Sarah L.; Tanaka, Aiko; Wilkman, Erica; Bailey, Michael; Bellomo, Rinaldo; GLobal OBservational Evaluations in the ICU (GLOBE-ICU) investigators.

In: Journal of Critical Care, Vol. 35, 01.10.2016, p. 126-132.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Defining the characteristics and expectations of fluid bolus therapy

T2 - A worldwide perspective

AU - Glassford, Neil J.

AU - Mårtensson, Johan

AU - Eastwood, Glenn M.

AU - Jones, Sarah L.

AU - Tanaka, Aiko

AU - Wilkman, Erica

AU - Bailey, Michael

AU - Bellomo, Rinaldo

AU - GLobal OBservational Evaluations in the ICU (GLOBE-ICU) investigators

PY - 2016/10/1

Y1 - 2016/10/1

N2 - Purpose The purpose of the study is to understand what clinicians believe defines fluid bolus therapy (FBT) and the expected response to such intervention. Methods We asked intensive care specialists in 30 countries to participate in an electronic questionnaire of their practice, definition, and expectations of FBT. Results We obtained 3138 responses. Despite much variation, more than 80% of respondents felt that more than 250 mL of either colloid or crystalloid fluid given over less than 30 minutes defined FBT, with crystalloids most acceptable. The most acceptable crystalloid and colloid for use as FBT were 0.9% saline and 4% albumin solution, respectively. Most respondents believed that one or more of the following physiological changes indicates a response to FBT: a mean arterial pressure increase greater than 10 mm Hg, a heart rate decrease greater than 10 beats per minute, an increase in urinary output by more than 10 mL/h, an increase in central venous oxygen saturation greater than 4%, or a lactate decrease greater than 1 mmol/L. Conclusions Despite wide variability between individuals and countries, clear majority views emerged to describe practice, define FBT, and identify a response to it. Further investigation is now required to describe actual FBT practice and to identify the magnitude and duration of the physiological response to FBT and its relationship to patient-centered outcomes.

AB - Purpose The purpose of the study is to understand what clinicians believe defines fluid bolus therapy (FBT) and the expected response to such intervention. Methods We asked intensive care specialists in 30 countries to participate in an electronic questionnaire of their practice, definition, and expectations of FBT. Results We obtained 3138 responses. Despite much variation, more than 80% of respondents felt that more than 250 mL of either colloid or crystalloid fluid given over less than 30 minutes defined FBT, with crystalloids most acceptable. The most acceptable crystalloid and colloid for use as FBT were 0.9% saline and 4% albumin solution, respectively. Most respondents believed that one or more of the following physiological changes indicates a response to FBT: a mean arterial pressure increase greater than 10 mm Hg, a heart rate decrease greater than 10 beats per minute, an increase in urinary output by more than 10 mL/h, an increase in central venous oxygen saturation greater than 4%, or a lactate decrease greater than 1 mmol/L. Conclusions Despite wide variability between individuals and countries, clear majority views emerged to describe practice, define FBT, and identify a response to it. Further investigation is now required to describe actual FBT practice and to identify the magnitude and duration of the physiological response to FBT and its relationship to patient-centered outcomes.

KW - Critical care

KW - Fluid bolus therapy

KW - Fluid resuscitation

KW - Hemodynamic optimization

UR - http://www.scopus.com/inward/record.url?scp=84994711591&partnerID=8YFLogxK

U2 - 10.1016/j.jcrc.2016.05.017

DO - 10.1016/j.jcrc.2016.05.017

M3 - Article

C2 - 27481747

AN - SCOPUS:84994711591

VL - 35

SP - 126

EP - 132

JO - Journal of Critical Care

JF - Journal of Critical Care

SN - 0883-9441

ER -